Jul 2, 2020 | Press Releases
– According to AIRM, “IVF with INVOcell is a simple, cost-effective, and highly rewarding methodology to increase access to care for assisted reproduction”- Industry forecasts suggest that only 1% to 2% of the estimated 150 million infertile couples...
Jun 29, 2020 | Press Releases
SARASOTA, Fla., June 29, 2020 – INVO Bioscience, Inc. (OTCQB: INVO), a medical device company focused on creating alternative treatments for patients diagnosed with infertility and developers of INVOcell®, the world’s only in vivo Intravaginal...
Jun 23, 2020 | Press Releases
SARASOTA, Fla., June 23, 2020 — INVO Bioscience, Inc. (OTCQB: INVO), (“the Company”) a medical device company focused on creating alternative treatments for patients diagnosed with infertility and developers of INVOcell®, the world’s only...
Jun 19, 2020 | Press Releases
Currently, it is estimated that only 1% to 2% of the estimated 150 million infertile couples worldwide are currently being treatedSARASOTA, Fla., June 19, 2020 — Today, Steve Shum, Chief Executive Officer of INVO Bioscience, Inc. (OTCQB: INVO) (OTCQB: INVOD), a...
May 22, 2020 | Press Releases
SARASOTA, Fla., May 22, 2020 – INVO Bioscience, Inc. (OTCQB: INVO), a medical device company focused on creating alternative treatments for patients diagnosed with infertility and developers of INVOcell®, the world’s only in vivo Intravaginal...
May 15, 2020 | Press Releases
Company to Participate in Virtual Investor Conference on May 20 at 2:00pm ET (Details Below)SARASOTA, Fla., May 15, 2020 — INVO Bioscience, Inc. (OTCQB: INVO), a medical device company focused on creating alternative treatments for patients diagnosed with...
